Amid the usual theatrics, efforts for a U.S.-China trade deal have fallen through, clobbering equities. Here are the moves to make now. Read More

We've recently posted big gains from undervalued stocks. We highlight a beaten-down sector with the potential to deliver even greater profits. Read More

We answer your queries on diverse topics, from next-gen wireless to dividend payers to marijuana's coming resurgence. Read More

Although options are considered short-term instruments, it's also possible to use them as part of a longer-term strategy. Read More

Sure, marijuana stocks are temporarily down. But recent trends indicate a sharp acceleration in pot-friendly laws. Read More

The trade war remains mired in stalemate but corporate managers are adjusting. That’s good news for stocks. Read More

As stocks hit new highs and risks of a correction get greater, here's how to protect your wealth. Read More

This record-setting rally shows plenty of animal spirits, but it wouldn’t take much for investors to hit the ground. Read More

We don't recommend buying stock in Teva Pharmaceutical, but there's a way to profit from Teva even if its share price doesn’t move. Read More

We’re seeing euphoria based on greed, not fundamentals. You need to rebalance your portfolio. Read More